SERA News and Press, Sera Prognostics Inc. From 03/09/23

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2022 Financial Results on March 22, 2023 PR Newswire SALT LAKE CITY , March 9, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: S...

Debunking the 3 Most Common Myths About Penny Stocks Penny stocks have long been a popular topic of debate in the world of investing. Often misunderstood and unfairly maligned, penny stocks have been the subject of a number of common myths and misconceptions that have led many investors t...

Health diagnostic company Sera Prognostics ( NASDAQ: SERA ) jumped ~62% pre-market Wednesday after announcing that its PreTRM test and physician care met the key goals in a study designed to evaluate its health benefits. The AVERT PRETERM TRIAL assessed infant health benefits when...

Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL PR Newswire PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital length-of-stay SALT LAKE CITY , ...

FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS PR Newswire – Sera's PreTRM® test-and-treat strategy helps build on Fors Marsh's commitment to investing in its empl...

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS PR Newswire - Clinical and economic benefits of the PreTRM® test and treat strategy illustrated...

Sera Prognostics, Inc. (SERA) Q3 2022 Earnings Conference Call November 9, 2022, 05:00 PM ET Company Participants Peter DeNardo - CapComm Partners, IR Greg Critchfield - President and CEO Jay Moyes - CFO Conference Call Participants Patrick Donnelly -...

Sera Prognostics press release ( NASDAQ: SERA ): Q3 GAAP EPS of -$0.35. Revenue of $87,000 compared to $23,000 for the same period of 2021. Total operating expenses were $11.3 million, up from $9.5 million for the third quarter of 2021. For further detail...

SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Nov. 9, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by pro...

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9 PR Newswire SALT LAKE CITY , Oct. 27, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), ...